Nuclear imaging of neuroendocrine tumours

A Sundin, U Garske, H Örlefors - Best practice & research Clinical …, 2007 - Elsevier
The diagnosis of neuroendocrine tumours (NETs) and monitoring of therapy in many
patients relies mainly on morphological imaging techniques such as computed tomography …

[HTML][HTML] A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner?

A Langer - BMC health services research, 2010 - Springer
Background A number of diagnostic tests are required for the detection and management of
cancer. Most imaging modalities such as computerized tomography (CT) are anatomical …

[HTML][HTML] SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates

B Schmidt, V Liebenberg, D Dietrich, T Schlegel… - BMC cancer, 2010 - Springer
Background This study aimed to show that SHOX2 DNA methylation is a tumor marker in
patients with suspected lung cancer by using bronchial fluid aspirated during bronchoscopy …

[68Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors' density …

A Watts, B Singh, H Singh, A Bal, H Kaur… - European Journal of …, 2023 - Springer
Purpose In vivo CXCR4 receptor quantification in different lung cancer (LC) sub-types using
[68Ga] Ga-Pentixafor PET/CT and to study correlation with quantitative CXCR4 receptors' …

Time course of early response to chemotherapy in non–small cell lung cancer patients with 18F-FDG PET/CT

C Nahmias, WT Hanna, LM Wahl… - Journal of Nuclear …, 2007 - Soc Nuclear Med
PET and 18F-FDG have the potential to follow the early metabolic response to
chemotherapy in patients with non–small cell lung cancer and to predict success or failure of …

Deep learning–based dynamic PET parametric Ki image generation from lung static PET

H Wang, Y Wu, Z Huang, Z Li, N Zhang, F Fu… - European …, 2023 - Springer
Objectives PET/CT is a first-line tool for the diagnosis of lung cancer. The accuracy of
quantification may suffer from various factors throughout the acquisition process. The …

In vivo imaging of 64Cu-labeled polymer nanoparticles targeted to the lung endothelium

R Rossin, S Muro, MJ Welch… - Journal of Nuclear …, 2008 - Soc Nuclear Med
Nanoparticles (NPs) targeting the intercellular adhesion molecule 1 (ICAM-1) hold promise
as a mean of delivering therapeutics to the pulmonary endothelium in patients with acute …

PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients

K Endo, N Oriuchi, T Higuchi, Y Iida, H Hanaoka… - International journal of …, 2006 - Springer
Positron emission tomography (PET) using 2-18 F-fluoro-2-deoxy-D-glucose (FDG), a
radioactive derivative of glucose, is an advanced imaging tool, based on the increased …

[HTML][HTML] Fracture risk evaluation of bone metastases: a burning issue

CB Confavreux, H Follet, D Mitton, JB Pialat… - Cancers, 2021 - mdpi.com
Simple Summary Major progress has been achieved in stage-IV bone metastatic patients to
control over the disease progression, thereby resulting in longer survival. Self-autonomy and …

Hypofractionated high-dose proton beam therapy for stage I non–small-cell lung cancer: preliminary results of a phase I/II clinical study

M Hata, K Tokuuye, K Kagei, S Sugahara… - International Journal of …, 2007 - Elsevier
Purpose: To present treatment outcomes of hypofractionated high-dose proton beam
therapy for Stage I non–small-cell lung cancer (NSCLC). Methods and Materials: Twenty …